VC Fund Dossiers

Rex's track record is genuinely impressive - about half of his 33 portfolio companies have already secured Series A funding, way above the 15.4% industry benchmark. The secret sauce isn't just his A16Z pedigree - it's his 1,500+ member founder-only Slack community that serves as his deal sourcing and portfolio support engine. As a solo GP, Rex makes all investment decisions himself, enabling rapid decision-making and personalized founder relationships. He's deliberately structured as a small, non-lead investor writing ~$500K checks to collaborate with top lead firms rather than compete with them. The downside? His LP base is loaded with fintech operators from SoFi, Plaid, Betterment who can provide co-investment and distribution support - so if you're building something that competes with his LP companies, that could get awkward fast.

CIC has genuinely unique deal flow through their exclusive Cambridge University relationship - this isn't marketing fluff, they literally have privileged access to the best IP coming out of one of the world's top research universities. Their track record speaks for itself: Bicycle Therapeutics IPO on NASDAQ, CMR Surgical unicorn, Gyroscope sold to Novartis for $1.5B, plus solid exits like Inivata ($390M) and PetMedix ($285M). Williamson brings serious credibility - 20 years US VC experience and co-chaired the UK government's university spinout review, so he knows the ecosystem inside out. Their Entrepreneur in Residence program is actually working - they're co-founding companies like Immutrin (just raised £65M from Frazier Life Sciences) by pairing seasoned operators with Cambridge academics. The downside? You're essentially betting on Cambridge staying relevant in deep tech, and they're very UK-focused if you want Silicon Valley-style growth.

Canaan is a solid, if unremarkable, mid-tier fund that does exactly what it says on the tin. They're not chasing the hottest trends or making splashy bets, which can actually be refreshing. Their partners have genuine operating experience and won't waste your time with MBA-speak. The downside? They can be painfully slow to move and their brand doesn't open as many doors as the tier-one funds. They're the reliable Honda Civic of VC - not sexy, but they'll get you where you need to go without breaking down.

CPPIB is the 800-pound gorilla that founders often don't realize is a VC player. They're not your typical Sand Hill Road fund—they're a massive pension fund that happens to do venture as part of a broader strategy. The good: they have ridiculous amounts of capital and genuinely long-term thinking. The bad: they move like the large institution they are, with multiple approval layers and slower decision-making. They're great as a late-stage investor when you need serious capital and don't need much hands-on help, but expect less startup-specific expertise than dedicated VCs. They won't hold your hand through product-market fit, but they also won't panic during market downturns.

Canapi is the rare VC fund that actually knows banking from the inside, which is both their superpower and their limitation. If you're building something that banks will actually buy and use, their introductions and regulatory guidance are genuinely valuable - they can get you meetings that would take months to land otherwise. But they think like bankers, not like software investors, so expect longer decision cycles and more conservative growth expectations. They're great at helping you navigate compliance and risk committees, less great at pushing you to move fast and break things. Perfect for founders who want to build sustainable fintech businesses rather than chase consumer viral growth.

Canary is solid but not spectacular - they're the safe choice for Brazilian B2B startups who want competent investors without drama. The team knows their stuff operationally and won't waste your time, but don't expect them to open Silicon Valley doors or lead your Series B. They're particularly strong on unit economics and scaling playbooks, which is great if you need that discipline, less great if you're still figuring out product-market fit. Word is they're supportive but not warm and fuzzy - expect regular check-ins about your numbers.

Canvas is what happens when experienced enterprise investors start their own shop and actually improve on the model. They're genuinely helpful post-investment without being micromanagers, and their enterprise rolodex is legit. Rebecca Lynn in particular has a reputation for being straight with founders about market dynamics and helping them avoid common scaling pitfalls. The fund is still relatively small which means you get real partner attention, not associate management. That said, they're pretty selective and won't chase hot deals just for FOMO - which is either great news or bad news depending on your perspective.

Canyon Creek punches above their weight in competitive deals by moving fast and offering genuine operational value, especially for technical founders who want hands-on product guidance. David Weiden has a track record of spotting category-defining companies early, but his involvement style isn't for everyone - he'll push hard on product strategy and hiring decisions. Sarah's fintech expertise is solid, though she's still building her investing reputation. The fund's relatively small size means you'll get real attention, but they can't lead large rounds or provide massive follow-on capital. Good choice if you want engaged investors who actually understand your product.

CapHorn got acquired by Anaxago in 2022, which means they're now part of a crowdfunding platform empire rather than a pure VC. They've got one unicorn (Ledger) and decent exits, but let's be real - this is a solid mid-tier French fund, not the next Sequoia. They talk up their conviction plays like Worldia, which survived COVID, but that's table stakes for any decent VC. With 14 team members and no board seats, they're more financial investors than hands-on partners. The Anaxago integration could be a plus for deal flow and follow-on capital, or it could mean more bureaucracy and less focus. The proof will be in Fund 3 performance.

Capital Invent is permanently closed according to Crunchbase, though their LinkedIn remains active, which suggests they're either winding down investments or operating in ghost mode. The fund was run by serial entrepreneur Heberto Taracena, who had a solid exit with Metroscubicos to Time Inc, giving him credibility in the Mexican internet space. Their latest investment was in September 2022, and they made 28 total investments - respectable volume for a regional Mexican fund. The team had real operating experience, which is rare in LatAm VC, but the fund appears to have run its course without raising a follow-on vehicle.

Capital One Ventures is the corporate VC arm that actually behaves like a corporate VC arm - meaning they're laser-focused on strategic value, not just financial returns. They're solid partners if your startup could genuinely benefit from Capital One's customer base, data, or banking infrastructure. But don't expect them to lead rounds or move quickly - they're methodical to a fault and everything gets filtered through 'how does this help Capital One?' The upside is real operational support and potential acquisition interest. The downside is they'll ghost you if the strategic fit isn't obvious, and their investment committee moves at big-bank speed.

Here's the real talk: I can't find any credible information about Capital Today as a Singapore-based VC fund. Their website doesn't provide useful content, and they don't appear in any major VC databases or industry lists for Singapore. This could mean they're either extremely stealth, very new, or potentially not an active fund. Before taking any meeting, founders should verify this fund actually exists and has real capital to deploy - ask for recent portfolio examples, fund size, and partner backgrounds.

CapitalG is Alphabet's growth equity arm, which means they come with the ultimate strategic asset: Google's platform, data, and distribution. The good news is they're genuinely founder-friendly and don't push Google partnerships - they let value emerge naturally. Partners like David Lawee have serious operator credibility and the fund moves fast on decisions. The potential downside? Taking Google money can create competitive dynamics with other tech giants, and some founders worry about information sharing (though CapitalG maintains strict walls). They're particularly strong for companies that can benefit from Google Cloud, search traffic, or Android/Play Store distribution.

Capnamic is the German VC equivalent of that reliable friend who shows up with tools when you're moving apartments. They're genuinely founder-friendly without the Silicon Valley theatrics - the 'Bullshit Buzzer' in their conference room tells you everything about their no-nonsense approach. Christian Siegele's 3i pedigree shows in their disciplined deal process, and they actually follow through on follow-on funding commitments (novel concept, right?). The track record speaks for itself: LeanIX to SAP, Adjust to AppLovin, Staffbase hitting unicorn status. They're particularly strong in DACH B2B software where their corporate LP network creates real value for portfolio companies. The downside? They're very focused on the German-speaking market, so if you're not planning to build there or serve that market, look elsewhere.

Capricorn is one of the OG climate tech funds that survived the cleantech 1.0 crash and learned hard lessons about market timing and technology readiness. They're legitimately thesis-driven rather than just trend-chasing, but this means they can be slow to move on deals outside their wheelhouse. Their partners have real operational experience and corporate connections that matter for B2B climate companies. The downside is they can be overly conservative on valuations and sometimes miss fast-moving opportunities while they're doing extensive diligence on market dynamics.

Capricorn is the rare European VC that actually walks the walk on deep tech and sustainability—they've been doing cleantech since 2007, way before it was cool again. With 2 unicorns (Electric Hydrogen and Xanadu) in their portfolio and a track record spanning 26 years, they're not just another generalist fund pretending to understand hard science. Jos Peeters is a proper physics PhD who's been in the game for over three decades and built the European VC infrastructure we know today. The team genuinely gets technical due diligence, but here's the catch: they're very Belgian in their approach—methodical, relationship-focused, and not flashy. They invest mostly in Belgium (28 companies) and Netherlands (9 companies), so if you're not in their geographic sweet spot or willing to relocate there, you might find yourself on the outside looking in.

Capstar is a solid, no-nonsense Austin fund that actually knows how to help B2B software companies grow. They're not flashy or trying to be the next big brand name, but that's exactly why they work well for founders who want investors focused on building businesses rather than building their own profiles. The partners have real operating experience and don't just spray and pray. However, they're still relatively small and their network outside of Texas isn't as strong as coastal funds. If you're building enterprise software and want investors who will roll up their sleeves, they're worth talking to.

Song Eun-kang has built a solid reputation as Korea's 'guardian angel' for early-stage companies, with legendary wins like 20x returns on Danggeun Market (Karrot) - they got in below 10 billion won valuation and it's now worth 3 trillion won. The fund punches above its 200 billion won (~$168M) AUM with 3 unicorns in portfolio including FADU, Kurly, and Sendbird. Song focuses heavily on execution ability and team collaboration over flashy pitches, which explains their early bets on overlooked winners. However, their social media presence is nearly nonexistent and they're very Korea-focused - don't expect much hand-holding on global expansion or Silicon Valley-style brand building.

Carabela is Angel Ventures Guadalajara's seed fund that started investing in November 2020, so they're relatively new but backed by a firm with 10+ years of track record. Javier gives solid, founder-friendly advice about burn rates and runway, suggesting adjusting valuations to keep doors open with investors - pragmatic, not ego-driven. They're launching a $20M Fund II focused on deep tech startups founded by LatAm unicorn alumni, leveraging a network of 150+ tech founders. The fund appears genuinely focused on helping founders hit milestones rather than just writing checks. Small ticket sizes mean they're not lead investors, but they seem like the kind of early supporters who actually roll up their sleeves.

Allan openly admits there's 'a lot of BS in the funds stating they are value add' and says VCs should be humble about when to take board seats - in many cases Carao doesn't ask for board seats, preferring to get engaged through other means. This is refreshingly honest for a VC. Allan had no prior venture track record when starting Carao, which was 'even harder to get off the ground,' but managed to build momentum and grow their LP base to 40 members over 3 years. They've had limited exits so far (just 2 portfolio exits, latest being Megabite in March 2024), but they do bring real value through regional market expansion expertise and corporate structures knowledge from their PE backgrounds, plus a strategic alliance with EY. They're betting on an underserved market that could pay off big if Latin America's startup ecosystem matures as expected.

Caravela is the scrappy Brazilian fund that's actually backing winners while everyone else is chasing the same hot deals in São Paulo. Caravela is known both for their go-to market approach, having analyzed more than 3.5k companies in less than 4-years, and their rigorous analytical approach, seeking high returns and sustainable growth. Mario de Lara sits on Mottu's board - that's the motorcycle rental unicorn that hit R$1B ARR - and they co-led OCN's $86M Series A. When we met with Caravela, it was obvious they were going to be a great partner for the business. Caravela has a very impressive track record having backed many successful companies. The fund operates out of Curitiba (not the obvious choice) but their network reaches across LatAm. Brunna Zogbi who leads the platform team at Caravela works with founders to identify the best ways to help them and their companies get better. They're sector-agnostic but seem to nail fintech and B2B plays consistently. They focus on buying companies at fair prices and selling them at significantly higher values, aiming for a 30x return.

Cargill Ventures is the classic corporate VC with all the pros and cons that entails. The upside: they bring massive distribution, deep industry expertise, and can write meaningful checks. The downside: they're slow, bureaucratic, and everything needs to fit their strategic thesis. They're genuinely helpful if your tech can plug into Cargill's ecosystem, but don't expect Silicon Valley speed or pure financial returns focus. Decision-making can take forever because it involves multiple stakeholders across a 150-year-old commodity giant. If you're building something that could threaten Cargill's core business, look elsewhere.

Look, Carlyle has serious pedigree but also serious baggage. They built their early reputation on Washington insider connections - recruiting former defense secretary Frank Carlucci, James Baker, and George H.W. Bush during their 1990s defense industry focus. This led to 'war profiteering' allegations and perceptions of leveraging political influence for business gain. Under new CEO Harvey Schwartz (who made $187 million in 2023), they're trying to modernize, but employee reviews are mixed - 77% would recommend working there, yet complaints about long hours, politics, and senior management publicly mocking subordinates persist. Their DC headquarters gives them genuine policy insight that few PE firms can match, and they're explicitly integrating geopolitical perspectives into investment decisions. The track record speaks for itself - 18% annual returns and their best deal ever, China Pacific Life, generated billions in gains. If you can handle the politics and want serious scale and government connectivity, they're hard to beat. Just know you're getting into bed with the ultimate Washington power players.

This isn't your typical Sand Hill Road fund - CMU's endowment plays a very different game. They're patient capital with deep academic connections, which is fantastic if you're building something that benefits from research partnerships or CMU talent. The downside? They move at university speed, not startup speed, and their investment decisions go through academic committees. They're genuinely smart money if your tech aligns with their strengths, but don't expect the hustle mentality of traditional VCs. Think of them as a strategic investor with a 50-year time horizon.

Casdin is the rare life sciences fund where the founder actually knows what he's talking about - Eli wrote a prescient book on molecular medicine in 2011 and has been right about precision medicine disrupting healthcare. With $2.4B AUM and a track record including 38 IPOs and 6 unicorns, they're serious players who can write big checks and open doors. The catch? Eli is a one-man show and notoriously picky - he'll grill you on the science and business model until your head spins. They move slow (this is biotech after all) but when they commit, they're genuinely helpful with regulatory strategy and customer intros. Fair warning: they expect founders to be as obsessed with the data as they are.

Castle Island is one of the few crypto VCs that actually understands the technology rather than just chasing narratives. Nic Carter is a respected voice who won't bullshit you about market conditions or your business model. They're crypto purists who care more about building real infrastructure than quick flips. The downside? They can be crypto maximalists who might not appreciate pivots away from pure blockchain plays. They're also a smaller fund, so don't expect the massive checks or operational support of larger firms.

Catalyst is a solid, no-frills B2B shop that actually knows how to pick winners - their portfolio speaks for itself. Brad and Rick are former operators who get in the weeds and genuinely help with product and go-to-market strategy, not just intro-making VCs. They're not flashy or prolific on social media, which some founders love because it means they're focused on the work. The downside? They can be pretty selective and their process can feel slow if you're used to faster-moving funds. They also tend to have strong opinions about business models and won't hesitate to tell you if they think your approach is wrong.

This is Narayana Murthy's family office, which means you're getting the Infosys playbook applied to venture investing - obsessive focus on corporate governance, process over charisma, and long-term value creation. Corporate governance has been at the forefront since day one, with reputation protection being a key priority for this family office. Padaki is notably disciplined on valuations and won't chase inflated deals, warning that struggling startups are selling at 30-40% discounts. They explicitly push founders to build original solutions rather than copy Western models, focusing on global competitiveness and job creation in India. The manufacturing thesis expansion feels strategic given India's moment, but this isn't a fund that'll coddle you through governance issues or overlook fundamentals for growth-at-any-cost narratives.

This is classic old-school UK venture capital - the kind that's been around since 1999 and has the battle scars to prove it. They've delivered solid returns with 14 profitable exits since 2015 averaging 4.7x, including some standout wins like R2C Online at 12.6x and Accutronics at 9.1x. What's refreshing is they actually take board seats and get their hands dirty - each partner has direct portfolio responsibility and they're not afraid to help with hiring, customer introductions, and financial strategy. With £130m under management, they're mid-sized but experienced. The downside? They're a small team (2-10 employees) which means limited bandwidth, and their heavy life sciences focus means if you're not in healthcare/biotech, you're probably not their cup of tea. They seem genuinely committed to long-term value creation rather than quick flips, which is either exactly what you want or frustratingly slow depending on your timeline.

This is classic corporate VC - they have real money and industry expertise, but everything runs through the lens of 'could Caterpillar acquire this or become a customer?' They're genuinely helpful if you're building something that fits their industrial wheelhouse, with solid connections and pilot opportunities. The downside is they move at big company speed and every investment decision gets filtered through corporate strategy priorities. Don't expect them to lead rounds or move fast, but they're solid follow-on investors who actually understand heavy industry pain points.

Cathay Innovation is genuinely useful if you're serious about Asia expansion, but don't expect them to be your primary US growth driver. Their China network is real and valuable - they've actually helped portfolio companies navigate regulatory complexity and find local partnerships that matter. The partners know their stuff operationally, but they're not the flashiest brand name for Silicon Valley credibility. They write reasonable check sizes for European growth stage but can be slow to decision-making due to cross-border coordination. If Asia is core to your strategy, they're worth the conversation. If it's just nice-to-have, there are faster, more focused options.

Cathexis is solid but regional - they're the go-to shop if you're building enterprise software in Texas or adjacent to energy/industrial markets. Brad Burke actually knows operations, not just finance, which shows in their portfolio support. The downside? Their network gets thin outside Houston, and they're not writing the mega-checks that coastal funds throw around. They're also fairly conservative - expect thorough due diligence and they'll want to see real revenue traction before writing checks. Good for founders who want genuine operational help over just capital and connections.

CAVU isn't your typical VC—they're operators who will literally redesign your packaging and walk you into Whole Foods buyer meetings. Poppi's nearly $2 billion exit to Pepsi and Once Upon a Farm's February 2026 NYSE debut prove their playbook works, but founders need to understand what they're signing up for. They're not passive investors—they'll reshape your packaging, rewrite your retail pitch, and walk you into buyer meetings. If you're not open to that level of hands-on involvement, CAVU isn't the right fit. Rohan's celebrity Rolodex is real (he literally discovered Poppi on Shark Tank), but the real value is their UNCOMMON platform that handles everything from creative to retail strategy. The downside? They describe themselves as "partners and operators first, investors second," which means expect them to have strong opinions about your business.

Here's the thing: CBRE doesn't actually run a traditional VC fund called 'CBRE Ventures.' They're a massive brokerage doing corporate venture investing to stay relevant in the proptech wave. Their approach is tactical - they throw money at companies that can make their brokers more efficient or give them data advantages. The $100M VTS investment shows they're serious about buying rather than building. Connor Hall seems sharp and well-connected in the ecosystem, but Vikram Kohli just left after 31 years, which creates some uncertainty around their tech strategy continuity. They're basically trying to tech-enable a traditional brokerage model rather than disrupt it.

CCV is the rare fund that actually delivers on its unicorn promises — 35% unicorn formation rate in first decade is legit eye-popping. Wei Zhou's KPCB pedigree runs deep and founders seem to genuinely respect his operator-first approach rather than typical VC interrogation style. The Ximalaya exit to Tencent for $2.4B shows they can navigate complex China market dynamics and actually get liquidity when others can't. But here's the thing — they're effectively a one-man show built around Wei's personal brand and network. CCV is the A-round leading investor in 80% of its investments which means they're conviction-driven, not spray-and-pray. The 'go global' messaging feels forced given their China-heavy portfolio, and you're basically betting on Wei's continued Midas touch in an increasingly challenging cross-border investment environment.

CDH is old-school China PE royalty with genuine institutional chops - these guys were making deals before most VCs knew where Beijing was. The founding team has been together for 30 years and actually knows how to execute massive, complex transactions (see: $7B Smithfield acquisition). They're not flashy Twitter VCs - they're the fund you want if you're a serious company needing serious capital and operational expertise. The downside? They move slow, do extensive diligence, and if you're not already a market leader or clear path to becoming one, you're probably not on their radar. Also, heavy China focus means geopolitical headwinds affect everything.

CDIB is Taiwan's legacy PE giant trying to evolve into a modern institutional player - think of them as the KKR of Taiwan, but with more government ties and less global polish. William Ho's CVC pedigree is legit and they've got serious capital ($25B+ AUM), but this is fundamentally a relationship-driven, Taiwan-centric shop that happens to have some Silicon Valley exposure. The 'China Plus' strategy sounds fancy but really means 'help Taiwanese companies expand to China and vice versa.' They're conservative, well-connected in Asia, and have genuine operational expertise in traditional industries, but don't expect the cutting-edge thesis or hands-on value creation you'd get from top-tier US funds. If you're building in hardware, manufacturing, or need Asia expansion, they're solid. If you're doing pure software or need Silicon Valley connections, look elsewhere.

CDP is Italy's €4 billion sovereign wealth fund playing venture capitalist - which means you get the benefits of patient capital and government backing, but also all the bureaucracy that comes with it. They have an initial €1 billion to deploy and are making 40-50 investments per year, so they're not exactly selective. The real power here is Francesca Bria - she's the rare government appointee who actually gets technology and has street cred from transforming Barcelona's smart city approach. Under Resmini they grew from €230M to €4B AUM in 3 years, which is impressive scaling but raises questions about quality control. They're essentially the Italian government's attempt to bootstrap a venture ecosystem, so expect slower decision-making but also less pressure for quick exits since they're playing the long game for Italy's economic development.

CDPQ brings serious capital and patient money, but you're dealing with a pension fund, not a traditional VC shop. The upside: they write big checks, don't need quick exits, and have deep pockets for follow-ons. The reality check: decision-making can be glacial, they're risk-averse by nature, and you'll navigate more bureaucracy than a typical fund. They're excellent for growth-stage companies that want stability over speed, but if you need fast decisions or aggressive growth strategies, look elsewhere. Their Quebec focus means they really understand the Canadian market, which is gold if that's your target.

CE Ventures is essentially a China-market access fund masquerading as a traditional VC. They help companies enter and accelerate in the Chinese market, find strategic investors in China, and manage relations there - Corephotonics insisted Kan sit on their board despite CreditEase only holding 1% because of his China market contribution. They perform 22 percentage points less than average on lead investments but commit exit 21 percentage points more often than other VCs. The real value prop isn't their capital - it's their CreditEase parent company's massive Chinese network. If you don't need China market entry, you're probably talking to the wrong fund. Fair warning: if your startup has 5+ founders, chances of getting funded are low.

Cedro Capital is the real deal in Brazil's underserved central region, but they're not playing in the big leagues yet. Since 2016, they've invested in 19 IT companies and conducted 5 exits, which shows they know how to spot winners and get out profitably - a rarity in Brazil. Their focus on the Center-West region is smart geographic arbitrage, as the Midwest corresponded to about 10% of the national GDP, but at that time it didn't have even 1% of Brazil's Venture Capital and Private Equity money. The partners have solid traditional finance backgrounds from pension funds and investment banks, not startup experience, which can be both good (disciplined due diligence) and bad (slower to understand tech trends). Their GovTech fund with KPTL is genuinely innovative and growing fast, but their main fund's sweet spot of $1.5M means they're not writing the checks that move the needle for high-growth startups.

This is one of the few funds where the "operator-led" marketing actually matches reality. The three founding partners genuinely built massive hardware businesses (Flex went from $150M to $30B under their watch), so when they say they'll roll up sleeves, they mean it. The US-India corridor focus is prescient timing as geopolitical winds shift manufacturing. However, be prepared for very hands-on investors who will want deep involvement in operational decisions - this cuts both ways depending on your tolerance for strong opinions from experienced operators. Their portfolio has genuine technical depth (semiconductors, AI infrastructure, space tech) rather than just buzzword bingo, and the exits speak for themselves with IPOs like Robinhood and Credo. The downside? These guys have run $25B+ companies, so if you're looking for patient capital while you figure things out, this might not be your crowd.

Celtic House is the grown-up in the room of Canadian VC. They've been around since the 90s and actually know how to build companies, not just write checks. The Shopify early investment gives them serious street cred, but don't expect flashy marketing or Silicon Valley-style hype. They're operationally-focused former executives who will roll up their sleeves and help you figure out go-to-market strategy. The downside? They can be conservative and slow-moving compared to US funds, and their network skews heavily Canadian. If you're building boring enterprise software that makes money, they're gold. If you're building the next consumer social app, look elsewhere.

CEMEX Ventures is what happens when a century-old cement giant decides to actually care about the future instead of just talking about it. They just lost their longtime head Gonzalo Galindo after 8 years, which could be a hiccup or a fresh start—jury's out. What's not up for debate is their industrial muscle: they offer startups access to pilot opportunities, global commercialization networks, and real customer validation at scale, which most CVCs can only dream of providing. Their Construction Startup Competition has helped 44 winners raise over $448M, so they're clearly not just playing around. The downside? They admit to some early naivety and the pace can be glacial when you're dealing with a corporate that moves cement around the world. But if you're building something that needs real-world industrial validation and can handle corporate timelines, few CVCs can offer better access to actual construction sites and global infrastructure networks.

Centana is a solid, no-drama growth equity shop that does exactly what it says on the tin. The partners are experienced operators who actually understand SaaS metrics and won't waste your time with fluff. They're particularly strong at helping companies navigate the tricky $10-50M revenue stage where growth starts getting harder. The downside? They're not going to lead your Series A or take big swings on unproven markets. If you need patient capital and operational expertise for scaling proven business models, they're worth the conversation.

Cento Ventures is the grizzled veteran of Southeast Asian VC - they've been grinding since 2011 when most funds were still scared of the region. Cento's successful exits include 2C2P (acquired by Ant Financial), Coda Payments (strategic investments by Apis Partners), FoodRunner (acquired by FoodPanda/DeliveryHero) and Kaidee (acquired by OLX Middle East)... delivering superior outcomes to our investors, including the biggest VC trade sale exit in Southeast Asia in 2022 to-date. What sets them apart is they actually understand the nuanced differences between Thai, Indonesian, and Filipino markets rather than treating SEA as one blob. Dmitry's operator background at Yahoo! and IDG gives him real domain expertise, while Boon Ping brings serious corporate finance chops from his SPH Ventures days managing $70M+. They're known for rolling up their sleeves post-investment - not the type to just write checks and disappear. The downside? They can be slow to move and very thesis-driven, so if you're outside their wheelhouse or need quick decisions, look elsewhere.

CerraCap is flying under the radar, which could be good or concerning depending on what you're looking for. The lack of public portfolio bragging and partner spotlights suggests they're either very early stage themselves, intentionally discrete, or not playing the typical VC marketing game. For impact founders, this could mean more genuine mission alignment and less performative impact theater. However, the limited transparency makes it harder to gauge their actual value-add beyond capital. If you're meeting with them, dig deep on their operational support and network - the proof will be in the specifics, not the marketing materials.

CFV is one of the more established players in the Southeast, which means they actually know how to help companies scale beyond the regional market - a key differentiator from newer Southern funds. They have real operational chops and portfolio success stories, but their check sizes haven't kept pace with inflation and competitive rounds. David Gardner genuinely cares about founder success and will roll up his sleeves, though the fund can be slower to move than coastal VCs. If you're a B2B SaaS company that wants smart money with regional expertise and doesn't need a massive Series A, they're solid.

Chalmers Ventures is the real deal for deeptech - they're not just investors throwing money around, they're basically the commercialization arm of one of Europe's top tech universities. Ranked as one of the world's top ten university-based venture builders, launching around ten new startups annually. The Google acquisition of Atlantic Quantum is proof they can get deeptech from lab to billion-dollar exits. What makes them different is the evergreen structure - they're not under pressure to return capital to LPs in 7-10 years, so they can actually wait for deeptech timelines. Pontus Ottosson has serious operational chops from his previous CEO role, not just investment experience. The downside? They're very focused on Chalmers ecosystem companies, so if you're not connected to the university, you're probably not getting a look.

Change Ventures is the real deal - probably the most founder-friendly fund in the Baltics with genuine operational chops. They ranked among Europe's top 10 VCs by founder reviews on Landscape, based on speed, responsiveness and value-add, which is rare for a regional fund. The partners aren't just check-writers; they've actually built and exited companies themselves. Andris has two $100M+ exits, the Ojasaar brothers literally created Estonia's VC ecosystem, and founders consistently praise their hands-on support: 'We've not only received full support, but Change Ventures provided the right hands-on at the right time, even unasked. Could not wish for better investors for the stage we're in.' They move fast, give clear feedback even when passing, and have a unicorn (Veriff) plus a solid exit (Nordigen to GoCardless) to show for it.